2 results
Approved WMORecruiting
To demonstrate that in patients with a CHA2DS2-VASc score of 2 or higher and no history of AF, the use of the Preventicus Heartbeats App increases the detection rate of AF compared to usual care and to demonstrate that AF screening with the app is…
Approved WMORecruiting
- To evaluate the effect of treatment with evolocumab, compared with placebo, on the risk for coronary heart disease (CHD) death, myocardial infarction (MI), or ischemic stroke, whichever occurs first, in subjects at high cardiovascular risk without…